-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Goals and Initiatives for a Representative Clinical Trial in Terms of Diversity, Equity and Inclusion: Regulatory Perspective/FDA

Scientific Workshop on Defining Goals and Utilizing Tools for Enhancing Diversity, Equity and Inclusion (DEI) in Clinical Trials in Hematology
Program: Scientific Workshops
Session: Setting Realistic Goals for DEI in Hematology Trials
Friday, December 8, 2023, 3:00 PM-3:55 PM

Nicole Gormley, MD

US Food and Drug Administration, Bethesda, MD

Disclosures: No relevant conflicts of interest to declare.

See more of: Setting Realistic Goals for DEI in Hematology Trials
See more of: Scientific Workshop on Defining Goals and Utilizing Tools for Enhancing Diversity, Equity and Inclusion (DEI) in Clinical Trials in Hematology
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation >>